Literature DB >> 28755070

[Still's disease in children and adults].

C M Hedrich1, C Günther2, M Aringer3.   

Abstract

Systemic juvenile idiopathic arthritis (sJIA) is characterized by fever, arthritis, and other signs of systemic inflammation. Historically, sJIA was named Still's disease after George Frederic Still, who first reported patients. Individuals who manifest after the 16th birthday are diagnosed with adult onset Still's disease (AOSD). The pathophysiology of sJIA and AOSD are incompletely understood. Increased activation of inflammasomes and the expression of proinflammatory cytokines play a central role. S100 proteins, which can activate Toll-like receptors, thus, maintaining positive feedback loops, have also been detected at increased levels in sera from sJIA patients. Reduced expression of the immune-modulatory cytokine IL-10 may further contribute to immune cell activation and the production of proinflammatory molecules. Here, we discuss the clinical picture, differential diagnoses, the current pathophysiological understanding, and treatment options in sJIA and AOSD.

Entities:  

Keywords:  Adult onset Still’s disease; Cytokines; Inflammasome; Systemic juvenile idiopathic arthritis; Treatment

Mesh:

Substances:

Year:  2017        PMID: 28755070     DOI: 10.1007/s00393-017-0358-5

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  85 in total

Review 1.  Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?

Authors:  Peter A Nigrovic
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

Review 2.  Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis.

Authors:  Kiem Oen
Journal:  Best Pract Res Clin Rheumatol       Date:  2002-07       Impact factor: 4.098

3.  Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis.

Authors:  Cristina Meazza; Paola Travaglino; Patrizia Pignatti; Silvia Magni-Manzoni; Angelo Ravelli; Alberto Martini; Fabrizio De Benedetti
Journal:  Arthritis Rheum       Date:  2002-01

4.  Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.

Authors:  Hal M Hoffman; Martin L Throne; N J Amar; Mohamed Sebai; Alan J Kivitz; Arthur Kavanaugh; Steven P Weinstein; Pavel Belomestnov; George D Yancopoulos; Neil Stahl; Scott J Mellis
Journal:  Arthritis Rheum       Date:  2008-08

5.  Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agents.

Authors:  Ricardo A G Russo; María M Katsicas
Journal:  J Rheumatol       Date:  2009-05       Impact factor: 4.666

6.  The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families.

Authors:  Emma M Ogilvie; Mark S Fife; Susan D Thompson; Natalie Twine; Monica Tsoras; Marta Moroldo; Sheila A Fisher; Cathryn M Lewis; Anne-Marie Prieur; David N Glass; Patricia Woo
Journal:  Arthritis Rheum       Date:  2003-11

7.  Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms.

Authors:  Kejian Zhang; Jennifer Biroschak; David N Glass; Susan D Thompson; Terri Finkel; Murray H Passo; Bryce A Binstadt; Alexandra Filipovich; Alexei A Grom
Journal:  Arthritis Rheum       Date:  2008-09

8.  [Adult-onset Still's disease and its characteristic rash].

Authors:  C Sunderkötter; U Frieling; D Nashan; D Metze
Journal:  Hautarzt       Date:  1998-12       Impact factor: 0.751

9.  Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade.

Authors:  Virginia Pascual; Florence Allantaz; Edsel Arce; Marilynn Punaro; Jacques Banchereau
Journal:  J Exp Med       Date:  2005-04-25       Impact factor: 14.307

Review 10.  Treatment advances in systemic juvenile idiopathic arthritis.

Authors:  Timothy Beukelman
Journal:  F1000Prime Rep       Date:  2014-04-01
View more
  5 in total

1.  [Schnitzler syndrome].

Authors:  F F Gellrich; C Günther
Journal:  Z Rheumatol       Date:  2019-02       Impact factor: 1.372

2.  [Schnitzler syndrome].

Authors:  F F Gellrich; C Günther
Journal:  Hautarzt       Date:  2018-09       Impact factor: 0.751

3.  [Nonexudative pharyngitis with intermittent fever].

Authors:  A S Büchel; M Jungehülsing
Journal:  HNO       Date:  2021-08       Impact factor: 1.284

Review 4.  Different Chronic Disorders That Fall within the Term Juvenile Idiopathic Arthritis.

Authors:  Lucia M Sur; Remus Gaga; Emanuela Duca; Genel Sur; Iulia Lupan; Daniel Sur; Gabriel Samasca; Cecilia Lazea; Calin Lazar
Journal:  Life (Basel)       Date:  2021-04-27

5.  Application of the international league against rheumatism classification criteria for systemic juvenile idiopathic arthritis as a prognostic factor in patients with adults-onset Still's disease.

Authors:  Ji Won Yang; Eunyoung Lee; Ji-Yeon Seo; Ju-Yang Jung; Chang-Hee Suh; Hyoun-Ah Kim
Journal:  Pediatr Rheumatol Online J       Date:  2018-01-25       Impact factor: 3.054

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.